Midi Health offers brand-name and compounded GLP-1 care for women in midlife, with separate visit fees, dose-based prices, insurance, and clinical trade-offs.
Where we stand: Menova is independent. We do not sell medication or take payment for placement. We may earn a commission if you use a clearly marked provider link, at no extra cost to you. That does not change our verdict. This is editorial analysis and general education, not medical advice. We have not used Midi's GLP-1 program as a patient and do not imply personal testing.
Quick verdict
Midi's GLP-1 program is worth comparing if you want a live midlife-focused visit, have a PPO plan that may cover the clinical care, or want to discuss an FDA-approved brand as well as compounded alternatives. There is no membership fee.
It is less compelling for a cash-pay patient focused only on the lowest monthly medication price. The initial self-pay visit is $250, medication is separate, and Midi's compounded prices rise with dose: $165.90–$355 per four weeks for a GLP-1 injection and $210–$434 for a dual-action GLP-1/GIP injection.
The strongest reason to choose Midi is not a cheap vial. It is the ability to place weight care inside a broader live discussion of menopause, sleep, metabolic health, medications, and muscle preservation. That extra scope is useful only if you need and use it.
Prices and terms were checked on official pages in August 2026 and can change.
How Midi's GLP-1 care works
Midi is a virtual midlife-health clinic, not a medication subscription. You complete an intake and meet a licensed clinician by video. If medication is appropriate, Midi says the clinician can prescribe a brand-name GLP-1 to your pharmacy or a compounded injectable or sublingual product through a partner pharmacy.
A prescription is not guaranteed, and not everyone is a candidate. Midi's official price page says compounded medication prices include shipping and supplies. It does not charge a separate membership fee.
This review focuses only on Midi's weight-medication route. For its menopause care, clinician credentials, Medicare and Medicaid exclusions, read our full Midi Health review.
What it costs without insurance
There are two bills to calculate: clinical visits and medication.
Clinical care
- Initial self-pay visit: $250
- Continued-care self-pay visit: $150
- Membership: none
- Labs and other services: potentially separate
Compounded medication, four-week supply
- GLP-1 injection: $165.90–$355, depending on dose
- Dual-action GLP-1/GIP injection: $210–$434, depending on dose
- Sublingual GLP-1: $164–$275, depending on dose
- Sublingual dual-action GLP-1/GIP: $209–$460, depending on dose
Shipping and supplies are included in those compounded prices, according to Midi. Brand-name prescriptions go to your chosen pharmacy, so their cost depends on the drug, coverage, prior authorization, deductible, and available savings terms.
Do not budget from the starting dose alone. Ask which dose range the clinician commonly reassesses, how often follow-up visits are expected, and what happens to the medication bill if your dose changes.
What a first six months can include
Midi does not publish one all-in six-month figure because visit frequency, dose, and insurance vary. Build your own estimate from:
- The initial visit or insurance cost-sharing
- Expected continued-care visits
- Six four-week medication supplies at a realistic dose range
- Labs, if ordered and not fully covered
- Pharmacy deductible or copay for a brand-name drug
Ask for both routes: the likely price if an approved brand is covered and the likely price if it is not. Then compare that with the compounded route. A lower cash medication price is not automatically better if the formulation, evidence, or follow-up does not fit your needs.
Does insurance cover Midi's GLP-1 program?
Midi says qualifying patients can use insurance-covered visits and that it is in network with many PPO plans. Coverage is specific to the plan, state, clinician, diagnosis, and service. An insurer logo is not proof that your appointment will be covered.
Medication coverage is a separate decision. A plan can cover the visit but deny a weight-loss drug, require prior authorization, restrict the indication, or apply a high deductible. Before booking, ask Midi and your insurer:
- Is the scheduled clinician in network for my exact plan?
- What is my expected visit copay, deductible, and coinsurance?
- Which weight-management medications are on my formulary?
- What clinical criteria and prior authorization are required?
- Are the requested labs in network?
Midi says it cannot treat Medicaid or Medi-Cal patients, even on a self-pay basis. It does not participate in Medicare; Medicare beneficiaries may use the self-pay route under Midi's stated terms but cannot submit related claims.
Brand-name versus compounded medication
Midi says it prescribes brand-name GLP-1s to local pharmacies and also offers compounded injectable and sublingual formulations. These are not interchangeable categories.
FDA-approved products are reviewed for safety, effectiveness, manufacturing quality, formulation, route, and labeling. Compounded drugs are not FDA-approved and do not receive that premarket review. The FDA says compounded drugs should be used only when a patient's medical need cannot be met by an approved drug.
If Midi recommends compounding, ask for the exact active ingredient, route, concentration, dose, and dispensing pharmacy. Ask why the compounded product meets your individual need and how to verify the pharmacy's license. Do not assume trial results from an approved injection apply unchanged to a compounded sublingual product.
The FDA has also warned about dosing errors and warm shipments involving compounded injectable GLP-1s. Get the dose in both milligrams and the exact syringe units, request a demonstration if unclear, and contact the pharmacy before using a shipment that arrives warm, damaged, or poorly labeled.
Why the midlife focus can matter
Weight change during perimenopause can sit beside sleep disruption, hot flashes, insulin resistance, thyroid disease, iron deficiency, medication effects, or reduced activity. A GLP-1 can address appetite and weight for an appropriate patient, but it does not diagnose or treat menopause itself.
Rapid weight loss can also include lean mass. Ask how the plan will monitor protein intake, resistance training, strength, side effects, and whether the rate of loss is appropriate. This matters in midlife because muscle and bone are not expendable. Read GLP-1s in perimenopause and strength training during menopause before reducing the decision to a scale number.
Midi's broader scope makes these conversations possible; it does not guarantee their depth. Ask who will monitor each part and how often.
Who Midi's GLP-1 program may fit
Midi may fit someone who:
- Wants a live video visit rather than questionnaire-only prescribing
- Has a participating PPO plan or accepts the self-pay visit cost
- Wants to compare a covered brand with compounded alternatives
- Has other midlife symptoms that should be considered alongside weight
- Prefers no membership or long medication-plan commitment
It may not fit someone who:
- Uses Medicaid or Medi-Cal
- Needs the lowest predictable cash price
- Wants medication without paying for clinical visits
- Assumes the starting compounded dose will remain the long-term price
- Needs hands-on examination or urgent assessment
For a lower-priced asynchronous compounded route, compare our Telos Rx review. The service model and medication evidence differ, so compare more than price.
Questions to ask before booking
- What is the likely six-month total at my expected dose?
- Is an FDA-approved product clinically suitable and covered first?
- If compounded, why is it needed and which pharmacy will fill it?
- How often are video follow-ups required, and what does each cost?
- Which labs are required and who reviews them?
- How will strength, nutrition, side effects, and other medications be monitored?
- Who answers an urgent medication question outside a scheduled visit?
Frequently asked questions
How much are GLP-1 medications through Midi Health?
In August 2026, Midi listed compounded injectable GLP-1s at $165.90–$355 per four weeks and dual-action GLP-1/GIP injections at $210–$434, depending on dose. Sublingual options were $164–$460. Visits are separate.
Does Midi prescribe brand-name GLP-1s?
Yes. Midi says it can send brand-name GLP-1 prescriptions to a pharmacy. Whether a prescription is appropriate and covered depends on the patient and insurance plan.
Are Midi's compounded GLP-1s FDA-approved?
No. Compounded drugs are not FDA-approved. Midi says its partner compounding pharmacies are licensed and 503A-accredited, but that does not replace FDA approval of the product.
Does Midi charge a membership fee?
No. Midi says there is no membership fee. You pay for clinical care and medication, with insurance applied where eligible.
Before you book, the free 2-minute Menova self-check organizes your symptom picture, the free printable visit prep sheet is what the first consultation runs on, and the free blood test sheet covers what should be checked regardless of which service you use — no account, not a diagnosis, and your answers never leave your device.
Educational only. Not medical advice, diagnosis, or treatment. Prices, coverage, medication availability, regulation, and eligibility can change. Verify directly with Midi, the pharmacy, and your insurer.
Sources, checked August 2026: Midi Health — GLP-1 Pricing, Midi Health — Pricing & Insurance, Midi Health — Weight Management, FDA — Concerns With Unapproved GLP-1 Drugs, and NIDDK — Prescription Medications for Weight Management.